The human genome and the future of medicine

Medical Journal of Australia

Volumn 179, Issue 4, 2003, Pages 212-216

  Mattick, John S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DESIGNER DRUG; ERYTHROPOIETIN; GENE PRODUCT; GROWTH HORMONE; HEPATITIS B VACCINE; HUMAN INSULIN; PROTEIN; RNA; ZANAMIVIR;

ADOPTIVE IMMUNOTHERAPY; AGING; BASE PAIRING; CANCER; CLINICAL TRIAL; CYSTIC FIBROSIS; DEVELOPMENTAL GENETICS; DIAGNOSTIC TEST; DIFFERENTIATION; DNA DETERMINATION; DRUG FATALITY; DRUG RESPONSE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEALTH CARE COST; HEPATITIS B; HEREDITY; HUMAN; HUMAN GENOME; LIFESTYLE; MEDICAL ETHICS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PHARMACOGENOMICS; PHYSICAL DISEASE; POLYMERASE CHAIN REACTION; PREDICTION; REVIEW; RISK; THALASSEMIA;

EID: 0041926401     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05505.x     Document Type: Review

References (28)

1. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
2. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 2001; 291: 1304-1351.
3. GOLD: Genomes online database. Chicago: Integrated Genomics Inc. Available at: http://wit.integratedgenomics.com/GOLD/ (accessed Mar 2003).
4. Waterston RH, Lindblad-Toh K, Birney E et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002; 420: 520-562.
5. Aparicio S, Chapman J, Stupka E et al. Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes. Science 2002; 297: 1301-1310.
6. Graveley BR. Alternative splicing: Increasing diversity in the proteomic world. Trends Genet 2001; 17: 100-107.
7. Duboule D, Wilkins AS. The evolution of 'bricolage'. Trends Genet 1998; 14: 54-59.
8. Rubin GM, Yandell MD, Wortman JR et al. Comparative genomics of the eukaryotes. Science 2000; 287: 2204-2215.
9. Mattick JS. Non-coding RNAs: The architects of eukaryotic complexity. EMBO Rep 2001; 2: 986-991.
10. Mattick JS. Noncoding RNAs: A regulatory role? In: Nature Encyclopaedia of the Human Genome. London: Nature Publishing Group, 2003; in press.
11. Kapranov P, Cawley SE, Drenkow J et al. Large-scale transcriptional activity in chromosomes 21 and 22. Science 2002; 296: 916-919.
12. Okazaki Y, Furuno M, Kasukawa T et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full length cDNAs. Nature 2002; 420: 563-573.
13. Ronai Z, Yakubovskaya M. PCR in clinical diagnosis. J Clin Lab Anal 1995; 9: 269-283.
14. Goodfellow PN. Impact of genomics on healthcare. Overview. Br Med Bull 1999; 55: 305-308.
15. Findlay I, Matthews PL, Mulcahy BK, Mitchelson K. Using MF-PCR to diagnose multiple defects from single cells: Implications for PGD. Mol Cell Endocrinol 2001; 183 Suppl 1: S5-S12.
16. Collins FS, McKusick VA. Implications of the human genome project for medical science. JAMA 2001; 285: 540-544.
17. Zanders E. Impact of genomics on medicine. Pharmacogenomics 2002; 3: 443-446.
18. Williamson R, Duncan R. DNA testing for all. Nature 2002; 418: 585-586.
19. Dean PM, Zanders ED, Bailey DS. Industrial-scale, genomics-based drug design and discovery. Trends Biotechnol 2001; 19: 288-292.
20. Ward SJ. Impact of genomics in drug discovery. Biotechniques 2001; 31: 626-630.
21. Ji Y. The role of genomics in the discovery of novel targets for antibiotic therapy. Pharmacogenomics 2002; 3: 315-323.
22. Alaoui-Ismaili MH, Lomedico PT, Jindal S. Chemical genomics: Discovery of disease genes and drugs. Drug Discov Today 2002; 7: 292-294.
23. Rubanyi GM. The future of human gene therapy. Mol Aspects Med 2001; 22: 113-142.
24. Bauerschmitz GJ, Lam JT, Kanerva A, et al. Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. Cancer Res 2002; 62: 1266-1270.
25. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185-1193.
26. Marshall E. Clinical research. Gene therapy a suspect in leukemia-like disease. Science 2002; 298: 34-35.
27. Australian Law Reform Commission. Protection of human genetic information [ALRC inquiry website]. Available at: www.alrc.gov.au/inquiries/current/genetic/ (accessed Mar 2003).
28. Australian Law Reform Commission. Gene patenting [ALRC inquiry website]. Available at: www.alrc.gov.au/inquiries/current/patenting/ (accessed Mar 2003).